Analyst Ratings for The Medicines Company (MDCO) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/26/2019 | Goldman Sachs | Paul Choi | Upgrade | Buy (Neutral) |
55.00 (25.00) |
29.46 (84.90) |
188.19% | Details |
| 3/21/2019 | Roth/MKM » Updated 9/4/2019 |
Yasmeen Rahimi | New Coverage | Buy (N/A) |
72.00 (N/A) |
26.54 (84.90) |
219.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
